Cancer patients are susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2). Different antitumor treatments have attracted wide attention in the context of …

The present review summarizes up-to-date evidence addressing the frequently discussed
clinical controversies regarding the use of immune checkpoint inhibitors (ICIs) in cancer …

Breast cancer has historically been a disease for which immunotherapy was largely
unavailable. Recently, the use of immune checkpoint inhibitors (ICIs) in combination with …

The phenomenon of 'T cell exhaustion', a state of T cell dysfunction observed during chronic
infections and cancers, has been a major obstacle in mounting appropriate immune …

In Deutschland leben aktuell circa 4 Mio. Menschen, die in ihrem Leben eine
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …

Highlights•VPDs represent a serious issue for cancer patients.•The AIOM has been involved
in vaccination awareness since 2014.•Seasonal flu, pneumococcal and anti-SARS-CoV-2 …

Background We assessed cell-mediated immune (CMI) responses of influenza vaccination
in patients with cancer receiving immune checkpoint inhibitors (ICIs), which remain elusive …

The COVID-19 pandemic has lasted over 1 year and will not disappear in a short time. There
is no specific remedy against the virus as yet. Vaccination is thus far one of the most …

Seasonal influenza affects every country, community and, consequently, a large number of
individuals [1]. Recent estimates have recalculated the burden of global influenza. Each …

Background There is a concern that influenza vaccination may increase the incidence of
immune‐related adverse events in patients receiving immune checkpoint inhibitors (ICIs) …